In December, after more than four years of medical monitoring while keeping his early-stage prostate cancer secret from his family, Michael Nutter had the walnut-size organ removed.
Now, fully recovered — fully, he stressed — the former Philadelphia mayor is advocating that men undergo regular screening for prostate cancer with the PSA blood test.
“Get screened!” he said during an interview on Thursday at the Center City offices of public relations executive Jay Devine. “All you have to do is give a little blood. See where you are. It’s not like they’re drilling a hole in your head.”
Nutter, 63, is aware that prostate specific antigen (PSA) screening is far more controversial than when he began doing it at age 50 in 2008. Back then, his doctor (who is also his best friend from high school) recommended checking his PSA level, so Nutter did it.
Fast forward to today. All the expert groups that issue guidelines, including the American Urological Association, acknowledge a dilemma. Studies show automatic, one-size fits all screening saves very few lives, and leads to diagnosis and treatment of many cancers that would never cause harm if left undetected. Treatment may cause permanent urinary or sexual problems, or both. The guidelines say men should be informed of the risks, as well as the benefits, before deciding what to do.
Nonetheless, Nutter believes he has an “obligation” to encourage PSA screening because of his race. Black men are about 60% more likely to develop prostate cancer during their lives, and twice as likely to die of it than white men. In terms of individual risk, 1 in 6 Black men and 1 in 8 white men are diagnosed; 1 in 23 Black men and 1 in 42 white men die of the disease.